Partner with us
With biomedical innovation advancing rapidly, partnerships can help accelerate clinical advances and improve patient outcomes.
At AROA, we’re collaborating with innovators to address some of society’s most challenging healthcare issues and help unlock regenerative healing for everybody.
- Cleared in 40+ Countries
- 130+ peer-reviewed publications
- FDA & EU Compliant
Three paths to collaboration
We work with partners at different stages and with different goals.
Co-Development
Leverage our proven ECM platform, regulatory expertise, and manufacturing capabilities to bring your innovative product to market.
Strategic Partnerships
We pursue transformational licensing, acquisition, and other business development opportunities that can expand AROA’s impact.
Research Collaborations
We support research that advances scientific understanding and explores new approaches to address unmet clinical needs.
Made to be built on
Surgical soft-tissue reconstruction is rarely one-size-fits-all.
By working together, we can unlock the potential of regenerative healing and help support better outcomes for everybody.
Third-Generation Bioscaffold Technology
Sustainable Biomaterial Platform
Derived from the forestomach of pasture-raised sheep, the technology upcycles waste from the food industry and utilizes sustainable manufacturing designed to reduce environmental impact.
Extensive Regulatory Experience
FDA Quality Systems Regulations and EU MDR 2017/745 compliant manufacturing. Multiple product clearances in both the US and EU.
Backed by Clinical Evidence
Supported by substantial published clinical and mechanistic evidence describing the technology’s performance across a range of applications.
How we work
Building on a proven platform
Our team has the expertise to design, develop, and manufacture products tailored to your specific clinical needs and market requirements.
Why Choose Aroa:
- Design control expertise and comprehensive testing capabilities
- FDA Quality Systems Regulations and EU MDR 2017/745 compliant manufacturing
- ISO13485 accredited quality management systems
- End-to-end support from concept through regulatory submission
If you are interested in collaborating with us, submit your opportunity below.
Building value through strategic partnerships
We evaluate strategic partnership opportunities that may include licensing, technology transfer, acquisitions and other business development structures capable of expanding our impact in soft-tissue reconstruction and regenerative medicine.
We are particularly interested in opportunities where complementary technologies, capabilities or market access can create mutual value and address areas of unmet clinical need.
If you are interested in exploring a strategic partnership with us, please submit your opportunity below.
Advancing the science of regeneration
We support research collaborations that help address unmet clinical needs and strengthen the evidence base for regenerative healing.
Research collaborations may include material supply under a material transfer agreement, joint grant applications or grant-funded projects, and investigator-initiated research aligned with clearly defined scientific objectives.
For investigator-initiated research, please review our ‘Investigator-Initiated Research brochure’ before submitting your opportunity.
If you are interested in collaborating with us, please submit your opportunity below.
Investigator Initiated Research Program Brochure (PDF)
Tell us about your opportunity
Please provide as much relevant information as possible so we can assess your opportunity and direct it to the right team.
We will use the information you provide only to review your submission and contact you about next steps.